Rating History for Royalty Pharma (RPRX) by Scotiabank
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/13/2022 | Adam Buckham | New Coverage | Sector Outperform (N/A) |
53.00 (N/A) |
38.95 (28.11) |
-27.83% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/13/2022 | Adam Buckham | New Coverage | Sector Outperform (N/A) |
53.00 (N/A) |
38.95 (28.11) |
-27.83% | Details |
